Philips, Infraredx ink deal for resale of coronary artery disease imaging system

Royal Philips (Andover, MA) and Infraredx (Burlington, MA) have signed a non-exclusive resale agreement for Infraredx’s TVC Imaging System. Under the terms of the agreement, Philips will sell the system alongside its Allura interventional x-ray systems in North America and Europe, expanding its interventional cardiology portfolio of advanced live image guidance solutions, clinical informatics, and interventional tools.

Related: Intravascular imaging system detects cholesterol signature in heart attack patients 

Additional catheter-based intravascular imaging technologies, such as the TVC Imaging System, are being used to assess the structure and composition of plaques from within the blood vessel for coronary artery disease (CAD), and to guide the interventional treatment for better procedural outcomes.
The TVC Imaging System is an intravascular imaging system that integrates near-infrared (NIR) spectroscopy lipid core plaque (LCP) detection technology and intravascular ultrasound (IVUS) imaging to visualize the presence of plaques, quantify the degree of vessel stenosis (narrowing), and identify plaques prone to rupturing and causing dangerous blockages.

In March 2013, the two companies launched a software solution to enable the integration of the TVC Imaging System with Philips’ Allura Xper and AlluraClarity interventional x-ray systems. The software facilitates setup of the TVC Imaging System in conjunction with the Allura systems, and allows clinicians tableside control of the TVC Imaging System using the Allura system controls.
Clinicians can view a TVC composite image, which shows both the NIR spectroscopy image and the IVUS image, alongside the coronary angiogram (a contrast-enhanced x-ray image of the coronary arteries) on the Allura monitors. The TVC composite image boosts visualization of lipid core plaques, which are known to cause complications in percutaneous coronary intervention (PCI) procedures and suspected of being the principal cause of most heart attacks.  


Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Subscribe now to BioOptics World magazine; it's free!

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

Merz acquires laser tattoo removal device maker ON Light Sciences

Merz North America has acquired ON Light Sciences, which develops technologies to enhance laser-based dermatology procedures.

Shortwave-infrared device could improve ear infection diagnosis

An otoscope-like device that could improve ear infection diagnosis uses shortwave-infrared light instead of visible light.

Laser therapy extracts rare tumor that grew human hair, skin in boy's skull

About four years ago, a tumor comprised of human skin, hair, bone and cartilage was fast-growing inside a Ramsey, MN, 10-year-old youth's brain.

Low-level laser therapy could speed muscle recovery at Rio 2016 Olympics

The gold medal-winning women’s U.S. Gymnastics team is reportedly experimenting with infrared light therapy to alleviate pain and reduce swelling in its athletes. (Update: A spokesperson for ...

Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...



Twitter- BioOptics World